Abstract
Health facility delivery is one of the critical indicators to monitor progress towards the provision of skilled delivery care and reduction in perinatal mortality. In Ethiopia, utilization of health facilities for skilled delivery care has been increasing but varies greatly by region and among specific socio-demography groups. We aim to measure the prevalence and determinants of health facility delivery in the Amhara region in Ethiopia.
From December 2018 to November 2020, we conducted a longitudinal study from a cohort of 2801 pregnant women and described the location of delivery and the association with determinants. We interviewed a subset of women who delivered in the community and analyzed responses using the three delays model to understand reasons for not using health facility services. A multivariable poisson regression model with robust error variance was used to estimate the presence and magnitude of association between location of delivery and the determinants.
Of the 2,482 pregnant women followed through to birth, 73.6% (n=1,826) gave birth in health facilities, 24.3% (n=604) gave birth at home and 2.1% (n=52) delivered on the way to a health facility. Determinants associated with increased likelihood of delivery at a health facility included formal maternal education, shorter travel times to health facilities, primiparity, higher wealth index and having attended at least one ANC visit. Most common reasons mothers gave for not delivering in a health facility were delays in individual/family decision to seek care. The proportion of deliveries occurring in health facilities is improving but falls below targets. Interventions that focus on the identified social-demographic determinants to improve uptake of health facility delivery care are warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has been funded by the Bill & Melinda Gates Foundation (Grant number INV-010382 and INV-003612).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Boards (IRBs) of St Pauls Hospital Millennium Medical College (SPHMMC), Addis Ababa, Ethiopia, under approval number PM 23/274 and Boston Childrens Hospital, Boston, MA, United States, under approval number IRB-P00028224.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data use is governed by the Birhan Data Access Committee (DAC) and follows Birhan data sharing policy. All researchers who wish to access Birhan data can complete a Birhan data request form and submit it for decision by the Birhan DAC.
